A Randomised, Prospective Study, Assessing Changes in Cerebral Function in Treatment Naive HIV-1 Infected Subjects Commencing Either Boosted Atazanavir With Truvada or Boosted Darunavir With Maraviroc and Kivexa.
Phase of Trial: Phase IV
Latest Information Update: 12 Feb 2018
At a glance
- Drugs Lamivudine/abacavir (Primary) ; Maraviroc (Primary) ; Atazanavir; Darunavir; Emtricitabine/tenofovir disoproxil fumarate; Ritonavir
- Indications HIV-1 infections
- Focus Pharmacodynamics
- Acronyms CogUK
- 12 Feb 2018 Primary endpoint (Cognitive function) has not been met as per the results published in the AIDS.
- 12 Feb 2018 Results published in the AIDS
- 25 Feb 2016 Primary analysis of cognitive function were presented at the 23rd Conference on Retroviruses and Opportunistic Infections.